Thoratec Corporation

Skip to content

Overview

Webcast ImageWebcast
Thoratec Corporation at Credit Suisse Healthcare Conference (Replay)
11/12/14 at 10:00 a.m. MT
Webcast ImageWebcast
Thoratec Corporation at Canaccord Genuity Medical Technologies & Diagnostics Forum (Replay)
11/20/14 at 10:30 a.m. ET
THOR (Common Stock)
Price31.27Change- 0.04
Volume479,800% Change0.10%
11/25/2014 4:00 p.m. ETPricing delayed 20 minutes

Thoratec is the world leader in mechanical circulatory support with the broadest product portfolio to treat the full range of clinical needs for patients suffering from advanced heart failure. The company's products include the HeartMate LVAS and Thoratec VAD, with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag and PediMag / PediVAS product lines. Thoratec is headquartered in Pleasanton, California. For more information, visit www.thoratec.com.

Recent News

More >>
DateTitle 
11/06/14Thoratec Announces Presentations At Investor Conferences For November 2014
PLEASANTON, Calif., Nov. 6, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences. On Wednesday, November 12, the company will participate in the Credit Suisse 2014 Healthcare Conference.  D. Keith Grossman, President and Chief Executive Officer, will provide an update on the company beginning at 10:00... 
Printer Friendly Version
11/05/14Thoratec® Reports Third Quarter 2014 Results
- Revenue of $105.8 million for the third quarter of 2014 - GAAP net income per diluted share of $0.05, and non-GAAP net income per diluted share of $0.18 - Company adjusts full-year 2014 guidance for revenue to a range of $450 million to $460 million and for net income per diluted share to $0.70 to $0.80 on a GAAP basis and $1.20 to $1.30 on a non-GAAP basis PLEASANTON, Calif., Nov. 5, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical c... 
Printer Friendly Version
10/15/14Thoratec Schedules Third Quarter Conference Call, Webcast
PLEASANTON, Calif., Oct. 15, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the third quarter of fiscal year 2014 on Wednesday, November 5. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific Standard Time ... 
Printer Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.